Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic Leukemia.

about

Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic Leukemia.

Item

http://www.wikidata.org/entity/Q48557504

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic Leukemia.

@en

Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic Leukemia.

@nl

type

Item

label

Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic Leukemia.

@en

Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic Leukemia.

@nl

prefLabel

Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic Leukemia.

@en

Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic Leukemia.

@nl

P1476

Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic Leukemia.

@en

P2093

Luisa Strocchio

http://www.w3.org/2001/XMLSchema#string

Mattia Algeri

http://www.w3.org/2001/XMLSchema#string

Pietro Merli

http://www.w3.org/2001/XMLSchema#string

P2860

Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities

How I treat juvenile myelomonocytic leukemia

Targeting RAS signalling pathways in cancer therapy

Bedside to bench in juvenile myelomonocytic leukemia: insights into leukemogenesis from a rare pediatric leukemia

RAS diseases in children

Myeloproliferative disorder in Noonan syndrome

Germline KRAS mutations cause Noonan syndrome

Nf1 deficiency causes Ras-mediated granulocyte/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukaemia

P304

129-143

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1080/17474086.2018.1421937

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Franco Locatelli

P577

2017-12-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29279013

http://www.w3.org/2001/XMLSchema#string